{"url_path":"/fda/drug/recalls/D-0771-2026","section_key":"summary","section_title":"DRUG Recall: Golden State Medical Supply Inc. — Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA","topic":"fda","document":{"doc_type":"drug-recall","doc_date":"2026-08-07","source_url":"https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0771-2026%22","accession_number":null,"cik":null,"ticker":null,"issuer_name":null,"edgar_url":null,"primary_entity_key":null,"primary_entity_name":"Golden State Medical Supply Inc."},"word_count":86,"has_tables":false,"body_markdown":"# FDA DRUG Recall: D-0771-2026\n\n**Recalling firm:** Golden State Medical Supply Inc.\n**Classification:** Class II\n**Status:** Ongoing\n**Type:** Voluntary: Firm initiated\n**Initiated:** 2026-08-07\n**Report date:** 2026-08-26\n\n## Product\nCarbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA\n\n## Reason\nCGMP deviations: tablets with black specks.\n\n## Affected lots\nLot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028\n\n## Distribution\nUSA Nationwide"}